Your browser doesn't support javascript.
loading
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus.
Zhu, Qian-Ying; Shan, Sisi; Yu, Jinfang; Peng, Si-Ying; Sun, Cong; Zuo, Yanan; Zhong, Lan-Yi; Yan, Shu-Mei; Zhang, Xiao; Yang, Ziqing; Peng, Yong-Jian; Shi, Xuanling; Cao, Su-Mei; Wang, Xinquan; Zeng, Mu-Sheng; Zhang, Linqi.
Afiliação
  • Zhu QY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China.
  • Shan S; Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
  • Yu J; NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Diseases Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, 100084, Beijing, China.
  • Peng SY; The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, 100084, Beijing, China.
  • Sun C; Bejing IDMO Company Limited, Beijing, China.
  • Zuo Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China.
  • Zhong LY; NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Diseases Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, 100084, Beijing, China.
  • Yan SM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China.
  • Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China.
  • Yang Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China.
  • Peng YJ; NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Diseases Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, 100084, Beijing, China.
  • Shi X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China.
  • Cao SM; NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Diseases Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, 100084, Beijing, China.
  • Wang X; State Key Laboratory of Oncology in South China, Department of Cancer Prevention Research, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China.
  • Zeng MS; The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, 100084, Beijing, China. xin
  • Zhang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center (SYSUCC), 510060, Guangzhou, China. zengmsh@sysucc.org.cn.
Nat Commun ; 12(1): 6624, 2021 11 16.
Article em En | MEDLINE | ID: mdl-34785638
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr / Anticorpos Neutralizantes / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 4 / Infecções por Vírus Epstein-Barr / Anticorpos Neutralizantes / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido